IL1B and breast cancer: Exogenous expression and secretion of IL-1β in a pre-clinical breast cancer model resulted in the recruitment and accumulation of myeloid suppressor cells, as well as the repression of CD8+ T cells [52], thus impairing their anti-cancer immune response.